Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elastase from Pseudomonas aeruginosa (LasB) is a zinc-dependent metalloprotease and a major virulence factor secreted by this bacterium. It degrades structural proteins, disrupts cellular junctions, and modulates host immune responses, contributing to tissue damage and infection establishment. LasB is an attractive target for anti-infective drug development.
Inhibition of metalloprotease activity, blocking degradation of elastin and pro-inflammatory cytokines
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Elastase (Pseudomonas aeruginosa) (LasB).